BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24068936)

  • 41. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.
    Naito T; Yasunaga JI; Mitobe Y; Shirai K; Sejima H; Ushirogawa H; Tanaka Y; Nakamura T; Hanada K; Fujii M; Matsuoka M; Saito M
    Retrovirology; 2018 Nov; 15(1):72. PubMed ID: 30400920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Human T-Cell Leukemia Virus Type 1 Basic Leucine Zipper Factor Attenuates Repair of Double-Stranded DNA Breaks via Nonhomologous End Joining.
    Rushing AW; Hoang K; Polakowski N; Lemasson I
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HTLV-1 bZIP factor: the key viral gene for pathogenesis.
    Matsuoka M; Mesnard JM
    Retrovirology; 2020 Jan; 17(1):2. PubMed ID: 31915026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis.
    Ma G; Yasunaga J; Matsuoka M
    Retrovirology; 2016 Mar; 13():16. PubMed ID: 26979059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells.
    Ma G; Yasunaga J; Fan J; Yanagawa S; Matsuoka M
    Oncogene; 2013 Sep; 32(36):4222-30. PubMed ID: 23045287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.
    Best I; López G; Verdonck K; González E; Tipismana M; Gotuzzo E; Vanham G; Clark D
    Immunology; 2009 Sep; 128(1 Suppl):e777-86. PubMed ID: 19740339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3' long terminal repeat.
    Gazon H; Lemasson I; Polakowski N; Césaire R; Matsuoka M; Barbeau B; Mesnard JM; Peloponese JM
    J Virol; 2012 Sep; 86(17):9070-8. PubMed ID: 22696638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Factor Upregulates the Expression of ICAM-1 To Facilitate HTLV-1 Infection.
    Fazio AL; Kendle W; Hoang K; Korleski E; Lemasson I; Polakowski N
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs.
    Anderson MR; Enose-Akahata Y; Massoud R; Ngouth N; Tanaka Y; Oh U; Jacobson S
    J Neuroimmune Pharmacol; 2014 Sep; 9(4):522-32. PubMed ID: 24845974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanisms of HTLV-1 infection and pathogenesis.
    Yasunaga J; Matsuoka M
    Int J Hematol; 2011 Nov; 94(5):435-42. PubMed ID: 21953273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.
    Polakowski N; Gregory H; Mesnard JM; Lemasson I
    Retrovirology; 2010 Jul; 7():61. PubMed ID: 20653953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein.
    Daian E Silva DSO; Cox LJ; Rocha AS; Lopes-Ribeiro Á; Souza JPC; Franco GM; Prado JLC; Pereira-Santos TA; Martins ML; Coelho-Dos-Reis JGA; Gomes-de-Pinho TM; Da Fonseca FG; Barbosa-Stancioli EF
    Virol J; 2023 Dec; 20(1):304. PubMed ID: 38115107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells.
    Hagiya K; Yasunaga J; Satou Y; Ohshima K; Matsuoka M
    Retrovirology; 2011 Mar; 8():19. PubMed ID: 21414204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HTLV-1 basic leucine-zipper factor, HBZ, interacts with MafB and suppresses transcription through a Maf recognition element.
    Ohshima T; Mukai R; Nakahara N; Matsumoto J; Isono O; Kobayashi Y; Takahashi S; Shimotohno K
    J Cell Biochem; 2010 Sep; 111(1):187-94. PubMed ID: 20506502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of HBZ in HTLV-1-Induced Oncogenesis.
    Zhao T
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26848677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HTLV-1 basic leucine zipper factor protects cells from oxidative stress by upregulating expression of Heme Oxygenase I.
    Rushing AW; Rushing B; Hoang K; Sanders SV; Péloponèse JM; Polakowski N; Lemasson I
    PLoS Pathog; 2019 Jun; 15(6):e1007922. PubMed ID: 31251786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of the HTLV-1 viral factors in the induction of apoptosis.
    Karimi M; Mohammadi H; Hemmatzadeh M; Mohammadi A; Rafatpanah H; Baradaran B
    Biomed Pharmacother; 2017 Jan; 85():334-347. PubMed ID: 27887847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization.
    Tanaka-Nakanishi A; Yasunaga J; Takai K; Matsuoka M
    Cancer Res; 2014 Jan; 74(1):188-200. PubMed ID: 24177179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization.
    Murata K; Hayashibara T; Sugahara K; Uemura A; Yamaguchi T; Harasawa H; Hasegawa H; Tsuruda K; Okazaki T; Koji T; Miyanishi T; Yamada Y; Kamihira S
    J Virol; 2006 Mar; 80(5):2495-505. PubMed ID: 16474156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strong correlation between tax and HBZ mRNA expression in HAM/TSP patients: distinct markers for the neurologic disease.
    Andrade RG; Gonçalves Pde C; Ribeiro MA; Romanelli LC; Ribas JG; Torres EB; Carneiro-Proietti AB; Barbosa-Stancioli EF; Martins ML
    J Clin Virol; 2013 Feb; 56(2):135-40. PubMed ID: 23127563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.